Navigation Links
IP-K extends research deal with Novartis Institute for Tropical Diseases
Date:12/2/2010

Dec. 03, 2010, Seoul, S. Korea Institut Pasteur Korea (IP-K) has signed an agreements to continue to mine the chemical compound collection of Novartis Institute for Tropical Diseases (NITD) of Singapore for new drug candidates.

IP-K's PhenomicScreen is a high-throughput, high-content visual screening platform that is ideally suited to identifying lead compounds. Over the past year, PhenomicScreen has been used to search for promising drugs within NITD's chemical compound collection. That deal has now been extended by two years to allow a further exploration of their chemical library.

Dr. Pablo Bifani, Project Team Head at NITD, welcomed his institute's new contract, noting that "The scientific approach we are taking with IP-K is greatly facilitating the selection of candidate compounds for further drug development."

IP-K's Dr. Jonathan Cechetto describes the advantages of PhenomicScreen as being that "The process selects novel targets, and only those which are functionally significant in the disease process". Dr. Priscille Brodin of IP-K adds that "The phenotypic approach does not rely on a predefined target, but rather simultaneously selects both chemical compounds and an unknown cellular target solely by the clearly discernible effect on the disease model".

Center Director of Core Technologies of Institut Pasteur Korea Dr. Veronica Soloveva said that "We are proud to be working with NITD in the fight against infectious diseases". Soloveva is satisfied that the agreement is a vindication of the institute's innovative approach to drug discovery. "Our PhenomicScreen technology is proven to increase the accuracy and speed of drug discovery," she says.


'/>"/>

Contact: Jean Kim
babunn@ip-korea.org
82-318-018-8041
Institut Pasteur Korea
Source:Eurekalert

Page: 1

Related biology news :

1. GenWay Biotech extends the You Test You program overseas
2. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
3. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
4. $5.1 million Army-Md. alliance speeds university research to market
5. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
6. Researchers describe first functioning lipidome of mouse macrophage
7. U of M researcher helps unlock 30 new genes responsible for early onset puberty
8. Stroke research takes 2 steps forward
9. Researchers find link between sugar, diabetes and aggression
10. Arjun Deb awarded Louis N. and Arnold M. Katz Basic Science Research Prize
11. Snakes on a rope: Researchers take a unique look at the climbing abilities of boa constrictors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):
(Date:5/22/2017)... ... 2017 , ... Baltimore biotech firm, PathSensors, announced that its ... developing and issuing recommendations to grow Maryland's biohealth industry and position the state ... , The recommendations are contained in a report from the Maryland ...
(Date:5/19/2017)... ... ... In response to the strong base of evidence supporting the use of ... of their Gait Trainer 3 with an Integrated Music Therapy option. This is the ... rehabilitating individuals with cerebral palsy, traumatic brain injury, stroke and Parkinson’s disease. , ...
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), a Great ... company continues to grow. CSM has doubled in size over the past six ... aggressive growth strategy. , Roger Gasper joins CSM as Chief Financial Officer. Roger ...
(Date:5/18/2017)... ... May 17, 2017 , ... USDM Life ... for the life sciences and healthcare industries, is honored that Jay Crowley ... Devices conference in Brussels, Belgium. , Crowley played a crucial role in the ...
Breaking Biology Technology: